KELLY MIKESELL: Open Payments
NPI 1023200888 · WEST JORDAN, UT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$4,353 in 188 payments from 50 companies in 2025. Trend: 2023 $3,869 · 2024 $5,178 · 2025 $4,353
Food & beverage: $3,973Education: $380
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 19 | $501 |
| Novartis Pharmaceuticals Corporation | 23 | $409 |
| Janssen Biotech, Inc. | 12 | $302 |
| Daiichi Sankyo Inc. | 10 | $279 |
| Incyte Corporation | 7 | $203 |
| Merck Sharp & Dohme LLC | 8 | $178 |
| PFIZER INC. | 11 | $165 |
| ABBVIE INC. | 7 | $144 |
| Genmab U.S., Inc. | 6 | $140 |
| Astellas Pharma US Inc | 2 | $123 |
Products named: Enhertu, SCEMBLIX, DATROWAY, KEYTRUDA, JAKAFI, IMFINZI, DARZALEX, EPKINLY.
Industry payments across UT — which companies pay providers there.
